fbpx
July 22, 2024

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL, (10mg/mL) Bags Due to an Individual Unit of Acetaminophen Overwrap Found to Have Contained a Labelled Bag of Dexmedetomidine HCL Injection (400mcg/100mL)

Summary Company Announcement Date: July 22, 2024 FDA Publish Date: July 22, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential presence of Dexmedetomidine […]
July 22, 2024

Patient Medication Information (PMI)

Background FDA is proposing to amend its human prescription drug labeling regulations to require a new type of Medication Guide—”Patient Medication Information” (PMI)—for prescription drug products […]
July 18, 2024

Drug Supply Chain Integrity

On this page U.S Drug Supply Chain is Among the Safest in the World The U.S. drug supply chain remains one of the safest in the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0